DLC - Democratic Leadership Council
Democratic Leadership Council Home
Search Tips 



PrintPrintable Version of this Article

Send this Article to a FriendSend this Article to a Friend


Ideas




Health Care
Medicare & Medicaid

DLC | Blueprint Magazine | February 11, 2003
Rx for Success
How Democrats lost the prescription drug debate -- and a new prescription for the future.

By Sarah Bianchi

Table of Contents

Prescription drug coverage was supposed to be just what the doctor ordered for Democrats in 2002. The party had a comprehensive plan endorsed by Democrats across the political spectrum -- from Sen. Zell Miller of Georgia to the late Sen. Paul Wellstone of Minnesota. The House Republican plan looked more like Swiss cheese than a real drug benefit.

But it was no magic pill. Instead of enjoying victories in the House and Senate, Democrats lost control of both chambers. In the process, they even lost the senior vote.

Republicans were disciplined in their efforts to blur the differences between their proposals and the Democratic plan. They banked on the fact that Americans aren't bean counters and that a fight over deductibles and so-called "doughnut holes" -- or gaps in coverage -- would be too hard to follow. They jammed their flawed plan through the House. When the Senate couldn't pass a plan, Republicans were ready to pounce, accusing Democrats of pandering to seniors, not offering real solutions. And now that Republicans have control of the whole government, there is little question that they will try to co-opt the prescription drug issue for the next two years.

Democrats need to be ready with a new plan. Here's what they should do:

First, don't try to win a bidding war. Democrats almost never win a fight over dollars, because all voters tend to hear is the reflexive demands of big-spending liberals. Crying out that $350 billion is inadequate not only sounds ludicrous outside Washington, it rings hollow in a sputtering economy with growing deficits.

Second, don't pit the party against the innovation promised by drugs. Drugs are a critical and growing part of health care, especially for people with chronic illnesses, which afflict three-fourths of all Medicare beneficiaries.

Instead, the real fight Democrats should wage is over the cost of drugs. The key is to ensure that beneficiaries and taxpayers get the best value from a drug benefit. Every year it becomes harder for the country to afford a Medicare drug benefit because prescription drug costs are soaring at double-digit rates. A comprehensive benefit with no gap and a reasonable premium is likely to cost about $1 trillion. If Democrats continue to try to win this issue through a bidding war, the price tag will become the central object of criticism -- and a valid one at that.

Moreover, Democrats have important and powerful allies on the cost issue. Holding down drug costs will not only help seniors who lack drug coverage but also provide relief to employers, employees, states, and insurers who are feeling the pain of rising costs.

Of course, the cost issue will only work for Democrats if they offer real answers. Price controls won't work. But restoring the principles of genuine competition and fiscal responsibility to the drug debate will be good for consumers and businesses alike.

Last year, the Senate passed legislation to bring more affordable generic drugs to the market. House Republicans and the Bush administration opposed that effort, resorting to a half-baked regulatory fix designed to give Republicans political cover. With the potential for saving as much as $60 billion, the push on generics should continue to be a centerpiece of the Democratic agenda.

However, more can be done. Many states are desperately trying to improve the price Medicaid pays for drugs. In fact, even states under conservative leaders like Florida Gov. Jeb Bush have taken steps to hold down drug prices. Democrats should adopt the best cost-cutting models. This will not only reduce costs for beneficiaries and taxpayers, it will force Republicans to show whether they have a plan to hold down costs.

At the same time, Democrats should stop promising the moon on prescription drugs. They should set their sights on a reasonable, achievable benefit. Last year, New Democrats offered an alternative that would have provided all seniors a discount on every trip to the pharmacy and ensured that no senior's savings were wiped out by drug costs. It would have limited annual drug costs to $4,000 and provided comprehensive coverage to low-income seniors. This approach contained no additional premiums for beneficiaries, so every senior would come out ahead.

Finally, Democrats should remember that misuse of prescription drugs is a big problem among seniors. Many are overmedicated because no single doctor is coordinating their care. In addition, everyone is at risk when a pharmacist misreads a doctor's handwriting and when no one checks to see whether the mixture of medications prescribed by different doctors is dangerous.

A robust cost-cutting and quality-improving agenda -- combined with a reasonable prescription drug benefit run though Medicare -- would give Democrats a plan to hold down health care costs and offer real help. That's a prescription that could help us all get well.

Sarah Bianchi is a senior policy analyst at the Democratic Leadership Council and a former domestic policy adviser to Vice President Gore.